ACRP blog

OCTOBER 3, 2023

Lessons learned from a new clinical research internship program held in central Pennsylvania last summer have helped prepare new and upcoming entrants for the research workforce, as well as to inform how the next generation of the program will evolve. alongside the Milton S. alongside the Milton S.

Clinical Research 59

Clinical Research Research Development Medicine 59

WCG Clinical

MAY 15, 2023

Study eDiaries are an example of a clinical research technology that can create additional burdens. As researchers, we must ask for patient feedback to better understand the ease of use of such patient technologies. As researchers, we must ask for patient feedback to better understand the ease of use of such patient technologies.

Clinical Research 52

Clinical Research Development Trials Research 52

XTalks

JUNE 10, 2021

Researchers at Massachusetts Institute of Technology (MIT) have designed the world’s first digital fabric fiber that contains digital devices which can sense, analyze and store health data, and use it to infer a person’s activity and state of health. Related: Google Launches AI-Based Dermatology Assist Tool.

Research 111

Research Development Containment Engineer 111

Pharmaceutical Technology

FEBRUARY 28, 2023

KFA-115 is under clinical development by Novartis and currently in Phase I for Melanoma. GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. The company offers generic medicines and biosimilars through Sandoz.

Generic Pharmaceutical 172

Generic Pharmaceutical Dermatology Clinical Trials Clinical Trials 172

Pharmaceutical Technology

APRIL 17, 2023

The company will provide regulatory advice to Incannex, and manage clinical trials to develop CannQuit and ReneCann products to treat addiction and immune-disordered skin diseases. The company will help in managing the clinical trials of the products once the regulators provide approvals for the proposed research and development programmes.

Dermatology 130

Dermatology Clinical Trials Clinical Trials Production 130

Drug Discovery World

OCTOBER 5, 2023

A research team at the Francis Crick Institute and Great Ormond Street Hospital (GOSH)/UCL Great Ormond Street Institute of Child Health have identified potential treatments for children with rare genetic conditions. The researchers have shown that problems with calcium underlie these progressive diseases.

Genetics 59

Genetics Research Gene Doctors 59

Scienmag

FEBRUARY 18, 2021

Mount Sinai researchers have discovered that Polycomb complexes, groups of proteins that maintain gene expression patterns, are essential for proper skin development, according to a paper published in Genes & Development on February 18.

Gene Expression 72

Gene Expression Development Research Gene 72

pharmaphorum

APRIL 29, 2022

An artificial intelligence-powered digital tool for diagnosing skin cancers developed by Skin Analytics has been cleared in the UK as a Class IIA medical device, setting up broader use of the technology in patient assessments.

Dermatology 145

Dermatology Containment Marketing Development 145

Trialfacts

MAY 16, 2024

More Study Details About the Research Center Location Research Center: University of California, San Francisco Location: San Francisco, California (UCSF Parnassus campus) Lead Researcher: Michael Lipnick, M.D. UCSF researchers aim to uncover why some pulse oximeters may be less accurate on individuals with darker skin tones.

Research 52

Research Dermatology Production Development 52

pharmaphorum

MARCH 24, 2021

After 27 years at Bayer, Jörg Möller has moved to LEO Pharma as the company’s EVP, global research and development. The post LEO Pharma’s new R&D lead on driving agility in drug development appeared first on. Is it a disease that has a high symptomatic disease burden, but is otherwise more of a nuisance?”

Development 52

Development Dermatology Drugs Research 52

Pharmaceutical Technology

FEBRUARY 28, 2023

KFA-115 is under clinical development by Novartis and currently in Phase I for Malignant Mesothelioma. GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data.

Generic Pharmaceutical 100

Generic Pharmaceutical Dermatology Clinical Trials Clinical Trials 100

The Pharma Data

OCTOBER 29, 2020

30, 2020 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ: INCY) announced today new data for baricitinib (marketed as OLUMIANT ® ) will be presented at the annual Fall Clinical Dermatology meeting taking place virtually October 29-November 1, 2020. vice president of immunology development at Lilly.

Dermatology 52

Dermatology Development Medicine Clinical Trials 52

Pharmaceutical Technology

FEBRUARY 28, 2023

Iptacopan hydrochloride is under clinical development by Novartis and currently in Phase III for Paroxysmal Nocturnal Hemoglobinuria. GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data.

Generic Pharmaceutical 100

Generic Pharmaceutical Dermatology Clinical Trials Clinical Trials 100

Pharmaceutical Technology

FEBRUARY 28, 2023

Iptacopan hydrochloride is under clinical development by Novartis and currently in Phase III for Glomerulonephritis. GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data.

Generic Pharmaceutical 100

Generic Pharmaceutical Dermatology Clinical Trials Clinical Trials 100

Pharmaceutical Technology

FEBRUARY 24, 2023

(Lopinavir + ritonavir) is under clinical development by Douglas Pharmaceuticals and currently in Phase I for Genital Warts (Condylomata Acuminata). GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data.

Contract Manufacturing 100

Contract Manufacturing Dermatology Hormones Production 100

Pharmaceutical Technology

FEBRUARY 24, 2023

(Lopinavir + ritonavir) is under clinical development by Douglas Pharmaceuticals and currently in Phase I for Cervical Intraepithelial Neoplasia (CIN). GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data.

Contract Manufacturing 100

Contract Manufacturing Dermatology Hormones Production 100

The Pharma Data

JUNE 26, 2023

Magdeburg researchers discover a new mechanism of cancer immune defense Modern immunotherapies boost the body’s own defenses against cancer. An interdisciplinary team of researchers from Magdeburg has now discovered a new mechanism that enables the immune system to also eliminate such invisible cancer cells.

Research 40

Research Dermatology Development 40

pharmaphorum

JULY 5, 2021

Spanish drugmaker Almirall has launched another search for early-stage research projects that it can partner in dermatology, its core area of expertise. ” Earlier iterations have focused on immuno-inflammatory skin conditions, novel targets for skin health and pharmacological validated research models in skin diseases.

Dermatology 57

Dermatology Pharma Companies Research Scientist 57

The Pharma Data

OCTOBER 1, 2021

The research, which spans clinical, health economics and outcomes research, translational, clinical pharmacology and preclinical presentations, highlights the breadth and depth of the company’s data on deucravacitinib, a first-in-class, oral, selective tyrosine kinase 2 (TYK2) inhibitor, also because the emerging dermatology pipeline.

Dermatology 52

Dermatology Trials Clinical Development Research 52

pharmaphorum

SEPTEMBER 8, 2022

As Kerry Capozza, Founder and Executive Director of Global Parents for Eczema Research explains, “There’s no easy solution, unless the eczema can be treated and brought under control”. It is hoped today’s event will serve as a “blueprint for the broader development and deployment of digital endpoints in medical product development”.

Dermatology 52

Dermatology Production Radiology Development 52

XTalks

MAY 23, 2024

Companies specializing in dermatology and skincare have developed a range of products aimed at protecting the skin from harmful UV rays. These include broad-spectrum sunscreens, protective clothing and innovative skincare products developed using antioxidants and other protective agents. 10), AbbVie Inc. (#11)

Life Science 72

Life Science Dermatology Drug Delivery Systems Medicine 72

Velocity Clinical Research

JULY 18, 2023

There’s a richness to the relationships you can develop with patients during the clinical trial process; you get to know their friends and family,” he says. Many of the people we’ve treated have come back to participate in later clinical trials because we’ve developed a relationship with them,” Muthiah says.

Clinical Trials 98

Clinical Trials Clinical Trials Trials Clinical Research 98

Outsourcing Pharma

FEBRUARY 2, 2021

While the technology has been found mostly in dermatological applications, its use in studies is expanding, according to Illingworth Research Group.

Clinical Trials 64

Clinical Trials Clinical Trials Dermatology Trials 64

pharmaphorum

SEPTEMBER 16, 2022

Atopic dermatitis (AD) is a highly prevalent chronic dermatological disease, with symptoms which include itching, dry skin, severe pain, and inflammation – all of which create considerable stress in the daily lives of patients and often negatively affect their day-to-day and long-term well-being. Findings presented at EADVC 2022.

Dermatology 70

Dermatology Trials Drugs Development 70

pharmaphorum

JANUARY 18, 2022

Almirall and IRB Barcelona (the Institute for Research in Biomedicine), will conduct research using molecular glue degraders, a new approach to the skin diseases under scrutiny. Researchers at Almirall have identified several proteins whose abnormal function is associated with inflammatory immune skin diseases.

Dermatology 52

Dermatology Protein Pharma Companies Research 52

The Pharma Data

JUNE 2, 2023

Zouboulis, President of the European Hidradenitis Suppurativa Foundation, Director of the Departments of Dermatology, Venereology, Allergology and Immunology, Städtisches Klinikum Dessau, and Founding Professor of Dermatology and Venereology at the Brandenburg Medical School, Germany. Find out more at [link].

Dermatology 52

Dermatology Medicine Production Marketing 52

Pharmaceutical Technology

FEBRUARY 18, 2023

The rNPV model is a more conservative valuation measure that accounts for the risk of a drug in clinical development failing to progress. Gevokizumab Overview Gevokizumab (XOMA-052) is developing gevokizumab for the treatment of metastatic colorectal cancer gastroesophageal cancer and colon cancer.

Generic Pharmaceutical 100

Generic Pharmaceutical Dermatology Antibody Development 100

pharmaphorum

JULY 5, 2022

With more than 500 dermatology clinical trials currently underway, it is often heard that there is a ‘’competition for participants’’. To help companies develop a nuanced understanding of how to optimise digital recruitment efforts to connect with a more diverse community of patients, Clariness’ whitepaper outlines.

Trials 90

Trials Clinical Trials Clinical Trials Dermatology 90

Drug Discovery World

FEBRUARY 5, 2024

Williams discussed the advantages of the company’s ‘disease agnostic’ small molecule degraders, and its success so far in translating results from preclinical to clinical tests in dermatology, inflammation and oncology indications. Product launches More than 400 exhibitors are at the event this year, many of whom are launching new products.

Gene Therapy 64

Gene Therapy Life Science Production Dermatology 64

The Pharma Data

DECEMBER 10, 2020

Spending several years with Sanofi in Paris, France as a Global safety officer, he then relocated to New Jersey, USA to work in Early and Late Stage Clinical Development in Immunology, when he became the Global Project Head of Dupixent, a medicine that has revolutionized the field of allergic and atopic diseases. positions he assumed in 2020.

Research 52

Research Doctors Doctor Medicine 52

The Pharma Data

NOVEMBER 10, 2020

HOUSTON–( BUSINESS WIRE )– Vapogenix, a clinical-stage company developing a new class of topical non-opioid, lidocaine-free analgesics, today announced it has been awarded a $1.5M Phase II Small Business Innovation Research (SBIR) grant ( Award No. 11, 2020 10:30 UTC. This work will allow Vapogenix to meet with the U.S.

Development 40

Development Cosmetics Dermatology Production 40

FDA Law Blog

OCTOBER 10, 2023

Dr. Beitz served in leadership positions in FDA’s Center for Drug Evaluation and Research for nearly three decades. We are thrilled that she is joining the firm and will add her expertise to our already exceptional Drug Development Team,” said JP Ellison, HP&M’s Managing Director.

Drugs 49

Drugs Dermatology Production Allergies 49

Trialfacts

DECEMBER 15, 2022

About the Research Centre. Research Centre: Skin Health Institute. Lead Researcher: Associate Professor Peter Foley, BMedSc, MBBS, MD, FACD. This is why researchers at the Skin Health Institute are working on a potential new treatment for eczema. Participants will be helping to advance medical research.

Research 52

Research Clinical Trials Clinical Trials Medicine 52

Drug Discovery World

DECEMBER 19, 2023

Each year, I am inspired by the commitment the community has in striving for better care for those living with dermatological conditions. LR: What is Novartis’ heritage in the development of medicines for immunological conditions? This focus has ensured patients are front and centre of our work.

Dermatology 59

Dermatology Medicine Branding Development 59

Pharmaceutical Technology

MAY 8, 2023

This protein also serves as a target for neutralizing antibodies, which can be used to develop for therapeutic as well as diagnostic applications. To further understand the key themes and technologies disrupting the pharmaceutical industry, access GlobalData’s latest thematic research report on Pharmaceutical.

Antibody 246

Antibody Vaccination Vaccine Dermatology 246

The Pharma Data

NOVEMBER 8, 2020

Almirall strengthens its leadership in medical dermatology by reinforcing its management team in France and obtaining reimbursement in France of Ilumetri ® (tildrakizumab) for treating moderate to severe chronic plaque psoriasis in adults. We have done this by both internal talent development as well as by external hires.

Dermatology 52

Dermatology Sales Marketing Production 52

Drug Discovery World

DECEMBER 19, 2022

Researchers have found that a topical gene therapy gel helps heal wounds in patients with life-threatening blistering skin disease epidermolysis bullosa (EB). . This was a life-changing event for Vincenzo,” said Peter Marinkovich, Associate Professor of Dermatology and Director of Stanford Medicine’s Blistering Disease Clinic.

Gene Therapy 52

Gene Therapy Gene Dermatology Clinical Trials 52